APA (7th ed.) Citation

S, C., B, B., S, I., G, V., AS, T., S, Z., . . . M, S. (2025). Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications. Gene therapy, 32(6), 581. https://doi.org/10.1038/s41434-025-00566-1

Chicago Style (17th ed.) Citation

S, Cattaneo, et al. "Genetic Mutations in HSV-1 Replication-defective Vectors: Implications for Their Safety in Gene Therapy Applications." Gene Therapy 32, no. 6 (2025): 581. https://doi.org/10.1038/s41434-025-00566-1.

MLA (9th ed.) Citation

S, Cattaneo, et al. "Genetic Mutations in HSV-1 Replication-defective Vectors: Implications for Their Safety in Gene Therapy Applications." Gene Therapy, vol. 32, no. 6, 2025, p. 581, https://doi.org/10.1038/s41434-025-00566-1.